Value
4.5/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 7.3 |
| EV/EBITDA | 0.0 |
| p ocf | 3.7 |
| Analyst target | 5.0 |
- ▸P/OCF: 30.7x (FFO proxy — REITs gated off P/E)
AHR · Why this verdict
Why American Healthcare REIT (AHR) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.8/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
American Healthcare REIT delivers exceptional cash conversion and 21% revenue growth but quality sits just below the minimum acceptable floor and a single counterparty representing more than half the portfolio creates a binary concentration risk that dominates the investment case.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Revenue is growing at 21% year over year, a pace that stands well above what the healthcare real estate sector typically generates and suggests that new facility additions or lease-up activity is meaningfully expanding the income base. Growth breakdown | Revenue growth should remain at or above 15% year over year for at least two consecutive quarters for this pillar to hold. | →Stable |
| CounterHealthcare REIT growth rates driven by acquisitions or operator expansions can prove episodic; if growth decelerates toward the sector median while the price-to-operating-cash-flow multiple stays near 28 times, the valuation will come under pressure. | ||
The trust converts earnings into cash at roughly 357% of net income — far above what the income statement alone suggests — and a financial strength score of 7 out of 9 indicates a fundamentally sound balance sheet that supports the distribution even if GAAP earnings appear modest. Quality breakdown | If this pillar holds, free cash flow relative to net income should remain above 200% over the next four quarters and the financial strength score should stay at 7 or above. | →Stable |
| CounterFree cash flow running well above net income in a REIT context can reflect working-capital timing or asset-disposition proceeds rather than durable operational generation; the ratio may normalize materially in future periods as those one-time tailwinds fade. | ||
A single manager accounts for 55.5% of the portfolio, meaning more than half of all cash flows depend on the financial health and continuity of one counterparty — a binary concentration that, if that relationship deteriorates, would disproportionately impair the entire enterprise. Bear case | Concentration risk would begin to ease if this counterparty's share of total portfolio revenue falls below 40% over four quarters through diversification or organic growth of other segments. | →Stable |
| CounterDeep concentration in one high-quality, aligned operator can be a feature rather than a flaw if that operator is well-capitalized and expanding, enabling stable cash flows and operational efficiencies a more fragmented tenant mix could not provide. | ||
Despite a high headline yield, the payout has been flagged as unsafe, suggesting distributions may be funded by sources beyond stable recurring cash flow and could be at risk of reduction if operating conditions soften even modestly. Catalyst breakdown | Dividend safety would improve if the financial strength score rises above 8 out of 9 and the dividend is maintained without an equity raise exceeding $100 million for four consecutive quarters. | →Stable |
| CounterREITs distribute by design in excess of GAAP net income using funds from operations as the true coverage metric; if FFO comfortably covers the dividend — even when GAAP net income does not — the 'unsafe' characterization may overstate the practical risk to the payout. | ||
Revenue is growing at 21% year over year, a pace that stands well above what the healthcare real estate sector typically generates and suggests that new facility additions or lease-up activity is meaningfully expanding the income base.
→StableGrowth breakdown
- Expectation
- Revenue growth should remain at or above 15% year over year for at least two consecutive quarters for this pillar to hold.
CounterHealthcare REIT growth rates driven by acquisitions or operator expansions can prove episodic; if growth decelerates toward the sector median while the price-to-operating-cash-flow multiple stays near 28 times, the valuation will come under pressure.
The trust converts earnings into cash at roughly 357% of net income — far above what the income statement alone suggests — and a financial strength score of 7 out of 9 indicates a fundamentally sound balance sheet that supports the distribution even if GAAP earnings appear modest.
→StableQuality breakdown
- Expectation
- If this pillar holds, free cash flow relative to net income should remain above 200% over the next four quarters and the financial strength score should stay at 7 or above.
CounterFree cash flow running well above net income in a REIT context can reflect working-capital timing or asset-disposition proceeds rather than durable operational generation; the ratio may normalize materially in future periods as those one-time tailwinds fade.
A single manager accounts for 55.5% of the portfolio, meaning more than half of all cash flows depend on the financial health and continuity of one counterparty — a binary concentration that, if that relationship deteriorates, would disproportionately impair the entire enterprise.
→StableBear case
- Expectation
- Concentration risk would begin to ease if this counterparty's share of total portfolio revenue falls below 40% over four quarters through diversification or organic growth of other segments.
CounterDeep concentration in one high-quality, aligned operator can be a feature rather than a flaw if that operator is well-capitalized and expanding, enabling stable cash flows and operational efficiencies a more fragmented tenant mix could not provide.
Despite a high headline yield, the payout has been flagged as unsafe, suggesting distributions may be funded by sources beyond stable recurring cash flow and could be at risk of reduction if operating conditions soften even modestly.
→StableCatalyst breakdown
- Expectation
- Dividend safety would improve if the financial strength score rises above 8 out of 9 and the dividend is maintained without an equity raise exceeding $100 million for four consecutive quarters.
CounterREITs distribute by design in excess of GAAP net income using funds from operations as the true coverage metric; if FFO comfortably covers the dividend — even when GAAP net income does not — the 'unsafe' characterization may overstate the practical risk to the payout.
Per-dimension breakdown
Quality
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 1.2 |
| ROA | 1.4 |
| Gross margin | 0.0 |
| Op margin | 2.6 |
| Net margin | 2.1 |
| Current ratio | 4.0 |
| FCF quality | 10.0 |
| Moat | 5.6 |
| Piotroski F | 7.8 |
- ▸Excellent cash conversion: 357% FCF/NI
- ▸Strong Piotroski F-Score: 7/9
Growth
8.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 7.7 |
| EPS growth | 10.0 |
- ▸Strong growth: 21% YoY
Momentum
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.4 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Overbought (RSI 71)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
7.4/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 6.5 |
| Analyst rating | 8.5 |
| Price target | 7.2 |
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸Negligible insider selling — $96,640 (0.001% of mkt cap)
Peer rank
5.1/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.8 |
| quality rank | 3.5 |
| growth rank | 6.9 |
Technical
3.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.8 |
| 52w position | 8.6 |
Risk (lower is worse)
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.9 |
| days to cover | 4.9 |
| volatility | 5.4 |
| put call | 7.7 |
| implied vol | 4.9 |
| beta | 8.2 |
| debt equity | 8.1 |
| news risk | 5.5 |
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| dividend safety | 4.2 |
| news activity | 8.0 |
- ▸Yield trap warning: high yield but unsafe
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (6)
- MOMENTUM:6.7>=5.5
- INSIDER:OK
- NEWS_BOOST:ANALYST_CLUSTER(5)
- EARNINGS_PROXIMITY:42d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:0.0<1.5@spot
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
0.04
Upside
+0.4%
Downside
11.2%
Sizing output
AVOID
SetupUNKNOWN — No clear chart pattern; technical signals are mixed
EdgeNO_EDGE — No clear edge identified
SuitabilityMODERATE — Balanced profile
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 8.8 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:0.0<1.5@spot.
The strongest dimensions are Growth at 8.8, Sentiment at 7.4, and Catalyst at 7.0; the weakest are Technical at 3.1, Quality at 3.9, and Value at 4.5. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 0.04 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1The trust converts earnings into cash at roughly 357% of net income — far above what the income statement alone suggests — and a financial strength score of 7 out of 9 indicates a fundamentally sound balance sheet that supports the distribution even if GAAP earnings appear modest.
Trip ifFree cash flow relative to net income falls below 150% for 2 consecutive quarters, suggesting the current 357% level is not repeating.
- P2Revenue is growing at 21% year over year, a pace that stands well above what the healthcare real estate sector typically generates and suggests that new facility additions or lease-up activity is meaningfully expanding the income base.
Trip ifRevenue growth falls below 15% year over year for 2 consecutive quarters, indicating the 21% pace has not been sustained.
- P3A single manager accounts for 55.5% of the portfolio, meaning more than half of all cash flows depend on the financial health and continuity of one counterparty — a binary concentration that, if that relationship deteriorates, would disproportionately impair the entire enterprise.
Trip ifTrilogy's share of total portfolio revenue falls below 40% for 2 consecutive quarters, indicating meaningful diversification from the current 55.5%.
- P4Despite a high headline yield, the payout has been flagged as unsafe, suggesting distributions may be funded by sources beyond stable recurring cash flow and could be at risk of reduction if operating conditions soften even modestly.
Trip ifDividend per share is maintained at or above the current rate for 4 consecutive quarters with no equity issuance exceeding $100 million, confirming the payout is self-sustaining.